drugset / Trial / NCT02029625

Compare the Pharmacokinetics of NVP-1205 and Coadministration of Rosuvastatin and Ezetimibe

NCT02029625

Phase 1 Completed 41 enrolled NVP Healthcare
RandomizedCrossoverOpen-labelScreening

Summary

The purpose of this study is to compare the pharmacokinetics of NVP-1205 and coadministration of rosuvastatin and ezetimibe.

Timeline

Start
2014-02
Primary completion
2014-03
Completion
2014-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ezetimibe Unknown Oral
Comparator Rosuvastatin Small molecule Oral

Indications